Skip to main content
. 2016 Mar 29;3(2):145–154. doi: 10.1007/s40801-016-0067-4

Table 6.

Disproportionality analysis results for reported H2 receptor antagonist-associated subacute cutaneous lupus erythematosus

Measure Ratio (95 % CI)
Proportional reporting ratio 3.74 (1.54–9.07)
Relative odds ratio 3.74 (1.54–9.08)
Relative reporting ratio 3.68 (1.52–8.92)

H2 receptor antagonist-associated SCLE cases = 7/220

CI confidence interval